Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Hubert Schrezenmeier and Bernd Jahrsdörfer.
Hubert Schrezenmeier
Connection Strength
2.587
Bernd Jahrsdörfer
  1. Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors. J Immunol. 2021 06 01; 206(11):2614-2622.
    View in: PubMed
    Score: 0.945
  2. Independent Side-by-Side Validation and Comparison of 4 Serological Platforms for SARS-CoV-2 Antibody Testing. J Infect Dis. 2021 03 03; 223(5):796-801.
    View in: PubMed
    Score: 0.932
  3. mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects. Vaccines (Basel). 2021 Aug 18; 9(8).
    View in: PubMed
    Score: 0.241
  4. Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies. Transfus Med Hemother. 2021 May; 48(3):137-147.
    View in: PubMed
    Score: 0.235
  5. Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients. J Clin Invest. 2021 07 15; 131(14).
    View in: PubMed
    Score: 0.060
  6. Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients. Sci Immunol. 2021 06 15; 6(60).
    View in: PubMed
    Score: 0.059
  7. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell. 2021 04 29; 184(9):2384-2393.e12.
    View in: PubMed
    Score: 0.058
  8. An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection. Antiviral Res. 2020 09; 181:104882.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.